List of insiders holdings for Axsome Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Antecip Capital LLC 10% Owner | 2015-12-04 16:52:32 | 7,351,729 0 | 7,351,729 | Form 13D |
Coleman Mark Director | 2023-09-15 18:30:32 | 25,097 403,856 | 428,953 | Form 4 |
JEFFS ROGER Director | 2024-03-15 20:05:27 | 120,756 46,912 | 167,668 | Form 4 |
TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 2024-02-29 18:20:18 | 135,078 0 | 135,078 | Form 4 |
Golubieski John Chief Financial Officer | 2017-08-08 16:25:42 | 132,000 0 | 132,000 | Form 4 |
Marek David C Chief Commercial Officer | 2020-03-19 21:19:02 | 70,517 0 | 70,517 | Form 4 |
Jacobson Mark L. CHIEF OPERATING OFFICER | 2024-02-29 18:34:06 | 50,852 0 | 50,852 | Form 4 |
Pizzie Nick CHIEF FINANCIAL OFFICER | 2024-02-29 18:25:17 | 44,496 0 | 44,496 | Form 4 |
Murdock Hunter R. General Counsel | 2024-02-29 17:39:05 | 36,549 0 | 36,549 | Form 4 |
Ames Constance Vice President, Finance | 2017-03-17 17:00:08 | 25,000 0 | 25,000 | Form 4 |
POTTER MYRTLE S Director | 2019-06-10 18:20:59 | 13,000 0 | 13,000 | Form 4 |
Kaye Randall Chief Medical Officer | 2015-12-24 13:02:23 | 0 6022 | 6022 | Form 4 |
Saad Mark E Director | 2024-02-29 18:34:13 | 1519 0 | 1519 | Form 4 |
Mahony Susan Director | 2024-02-29 18:18:57 | 191 0 | 191 | Form 4 |